跳至主要内容
临床试验/NCT05740904
NCT05740904已完成不适用

Efficacy and Safety of New Defocus Spectacle Lens in Preventing Progression of Myopia Compared With the Conventional Single-vision Spectacle Lens: a Randomized Controlled Trial Among Chinese Children

Zhongshan Ophthalmic Center, Sun Yat-sen University1 个研究点 分布在 1 个国家目标入组 174 人开始时间: 2023年3月23日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
174
试验地点
1
主要终点
Changes of spherical equivalent refraction (SER) at one year

研究概览

简要总结

The clinical effects of new technical spectacles with refractive correction function are mixed. A randomised trial is designed to compare the effects of new defocusing spectacle lenses and traditional aspheric spectacle lenses on myopia progression in Chinese children aged 6-14 years.

详细描述

Myopia has become the focus of global attention.

There has been a lot of evidence that soft bifocal contact lenses, corneal plastic lenses, low-concentration atropine and outdoor time can reduce the incidence and progress of myopia, while the clinical effects of new technical spectacles with refractive correction function are mixed. Among the strategies of myopia control through optical intervention, the clinical researches of the bifocal spectacle lens showed that the myopia progression can be slowed by about 50% in two years. However, for active children, wearing 1.50D binoculars may increase the risk of injury caused by falls. Moreover, DIMS (Defocus Incorporated Multiple Segments) spectacle lens which also reported that myopia can be effectively controlled is the effect of reducing the far-sighted defocus of omnidirectional off-axis aberration. Although the DIMS lens do not have the discomfort of wearing like the bifocal lens, because several small defocusing areas divide the imaging, the field of vision will feel uncomfortable vibration, or feel scattered light, which will hinder the field of vision.

Like DIMS lens, defocus spectacle lens aims to suppress hyperopia defocus caused by omni-directional off-axis aberration. The method is to set the focal depth extension area and optical center (refractive correction area) of astigmatism with relatively positive refractive power in the surrounding concentric circle area. The precise focusing position of astigmatism, that is, the defocusing amount of the forward refractive force as the equivalent spherical lens, is about 2.75D as the same as the DIMS lens. The change from the two straight focus lines in the front and back directions of astigmatism to the point image distribution of precise focus is very gentle, so there will be no sharp point image change like the DIMS lens, which can inhibit the discomfort of the field of vision being divided.

This study plans to design a randomised trial to compare the effects of new defocusing spectacle lenses and traditional aspheric spectacle lenses on myopia progression in Chinese children aged 6-14 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Care Provider, Outcomes Assessor)

入排标准

年龄范围
6 Years 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Aged 6 to 14 years;
  • Under the condition of bilateral cycloplegic autorefraction, the spherical refractive error of -1.00 to -3.50 D in each eye and astigmatism of not more than 1.50 D and anisometropia of not more than 1.00 D;
  • Best-corrected visual acuity of equal or better than 0.00 LogMAR (>= 1.0 as Snellen).
  • The intraocular pressure of 10 to 21mmHg.
  • Volunteer to participate in this clinical trial with signature of the informed consent form.

排除标准

  • History of eye injury or intraocular surgery;
  • Clinically abnormal slit-lamp findings
  • Abnormal fundus examination
  • Ocular disease, such as uveitis and other inflammatory diseases, glaucoma, cataract, fundus diseases, eye tumors, dominant strabismus, and any eye diseases that affect visual function;
  • Systemic diseases causing low immunity (such as diabetes, Down's syndrome, rheumatoid arthritis, psychotic patients or other diseases that researchers think are not suitable for wearing glasses);
  • Participation of the drug clinical trial within three month and the device clinical trial within one month;
  • Only one eye meets the inclusion criteria;
  • Unable to have regular follow-up
  • Participation of any myopia control clinical research trial within three months, and currently using rigid contact lenses (including nursing products), multifocal contact lenses, progressive multifocal lenses and other specially designed myopia control lenses, atropine drugs, etc.

研究组 & 干预措施

New defocus spectacle lens

Experimental

The children in the experimental group will wear new defocus spectacle lens and receive follow-up examinations every half year.

干预措施: New defocus spectacle lenses (Other)

Conventional aspheric single-vision spectacle lenses

Active Comparator

The children in the control group will wear conventional aspheric single-vision spectacles and receive follow-up examinations every half year.

干预措施: Convenional aspheric single-vision spectacle lenses (Other)

结局指标

主要结局

Changes of spherical equivalent refraction (SER) at one year

时间窗: 1 year

The difference of SER (Diopter) at one year compared with baseline SER. SER will be measured after cycloplegia.

次要结局

  • Changes of axial length (AL) at one year(1 year)
  • Change of anterior chamber depth (ACD) at one year(1 year)
  • Change of corneal power (CP) at one year(1 year)
  • Change of lens thickness (LT) at one year(1 year)
  • Visual scale score at six months(6 months)
  • Best corrected visual acuity(BCVA) at one year(1 year)
  • Binocular visual function at one year(1 year)
  • Visual scale score at one year(1 year)
  • Time length of wearing spectcales at one year(1 year)
  • Choroidal thickness at one year(1 year)
  • Safty of wearing the spectacle lens(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Efficacy and Safety of the New Defocus Spectacle... | 临床试验